Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 18-Sep-24 5:04 PM View:  | Chan Mitchell Chief Financial Officer | Regenxbio Inc. (RGNX) | 16-Sep-24 | Grant | 58,869 | -- | -- | 100% 0 to 58.87K | |
| 04-Sep-24 8:20 PM View: | Karabelas Argeris N Director | Regenxbio Inc. (RGNX) | 03-Sep-24 | Option Exercise | 10,000 | $3.76 | $37,600.00 | 89% 11.29K to 21.29K | |
| 04-Sep-24 8:20 PM View: | Karabelas Argeris N Director | Regenxbio Inc. (RGNX) | 03-Sep-24 | Planned Option Sale | 10,000 | $11.56 | $115,588.00 | (47%) 21.29K to 11.29K | |
| 12-Aug-24 4:58 PM View: | Mills Kenneth T. Director | Regenxbio Inc. (RGNX) | 08-Aug-24 | Option Exercise | 36,316 | $0.85 | $30,868.60 | 9% 408.04K to 444.35K | |
| 05-Aug-24 6:39 PM View: | Karabelas Argeris N Director | Regenxbio Inc. (RGNX) | 01-Aug-24 | Planned Option Sale | 10,100 | $13.51 | $136,454.00 | (47%) 21.39K to 11.29K | |
| 05-Aug-24 6:39 PM View: | Christmas Patrick J. Chief Legal Officer | Regenxbio Inc. (RGNX) | 01-Aug-24 | Grant | 56,446 | -- | -- | 49% 115.76K to 172.21K | |
| 05-Aug-24 6:41 PM View: | Pakola Steve Chief Medical Officer | Regenxbio Inc. (RGNX) | 01-Aug-24 | Grant | 58,386 | -- | -- | 54% 107.19K to 165.58K | |
| 05-Aug-24 6:38 PM View: | Danos Olivier Chief Scientific Officer | Regenxbio Inc. (RGNX) | 01-Aug-24 | Grant | 58,867 | -- | -- | 47% 126.22K to 185.08K | |
| 05-Aug-24 6:39 PM View: | Simpson Curran Chief Executive Officer Director | Regenxbio Inc. (RGNX) | 01-Aug-24 | Sale (Planned) | 100 | $15.00 | $1,500.00 | (< 1%) 170.14K to 170.04K | |
| 05-Aug-24 6:39 PM View: | Karabelas Argeris N Director | Regenxbio Inc. (RGNX) | 01-Aug-24 | Option Exercise | 10,100 | $3.85 | $38,874.00 | 89% 11.29K to 21.39K | |
| 30-Jul-24 5:01 PM View: | Simpson Curran Chief Executive Officer Director | Regenxbio Inc. (RGNX) | 29-Jul-24 | Sale (Planned) | 9,648 | $15.04 | $145,106.00 | (5%) 179.78K to 170.14K | |
| 30-Jul-24 5:01 PM View: | Karabelas Argeris N Director | Regenxbio Inc. (RGNX) | 29-Jul-24 | Option Exercise | 11,000 | $12.74 | $140,140.00 | 97% 11.29K to 22.29K | |
| 30-Jul-24 5:01 PM View: | Karabelas Argeris N Director | Regenxbio Inc. (RGNX) | 29-Jul-24 | Planned Option Sale | 11,000 | $15.05 | $165,495.00 | (49%) 22.29K to 11.29K | |
| 26-Jul-24 5:00 PM View: | Mills Kenneth T. Director | Regenxbio Inc. (RGNX) | 25-Jul-24 | Planned Option Sale | 15,369 | $13.96 | $214,501.00 | (4%) 423.4K to 408.04K | |
| 26-Jul-24 5:00 PM View: | Mills Kenneth T. Director | Regenxbio Inc. (RGNX) | 25-Jul-24 | Option Exercise | 15,369 | $3.76 | $57,787.40 | 4% 408.04K to 423.4K | |
| 26-Jul-24 5:00 PM View: | Mills Kenneth T. Director | Regenxbio Inc. (RGNX) | 24-Jul-24 | Planned Option Sale | 12,221 | $13.78 | $168,433.00 | (3%) 420.26K to 408.04K | |
| 26-Jul-24 5:00 PM View: | Mills Kenneth T. Director | Regenxbio Inc. (RGNX) | 24-Jul-24 | Option Exercise | 12,221 | $3.76 | $45,951.00 | 3% 408.04K to 420.26K | |
| 18-Jul-24 5:05 PM View: | Mills Kenneth T. Director | Regenxbio Inc. (RGNX) | 17-Jul-24 | Planned Option Sale | 2,210 | $13.77 | $30,439.90 | (< 1%) 410.25K to 408.04K | |
| 18-Jul-24 5:05 PM View: | Mills Kenneth T. Director | Regenxbio Inc. (RGNX) | 17-Jul-24 | Option Exercise | 2,210 | $3.76 | $8,309.60 | < 1% 408.04K to 410.25K | |
| 18-Jul-24 5:05 PM View: | Mills Kenneth T. Director | Regenxbio Inc. (RGNX) | 16-Jul-24 | Planned Option Sale | 200 | $13.76 | $2,752.00 | (< 1%) 408.24K to 408.04K | |
| 18-Jul-24 5:05 PM View: | Mills Kenneth T. Director | Regenxbio Inc. (RGNX) | 16-Jul-24 | Option Exercise | 200 | $3.76 | $752.00 | < 1% 408.04K to 408.24K | |
| 03-Jul-24 7:56 AM View: | Simpson Curran Chief Executive Officer Director | Regenxbio Inc. (RGNX) | 01-Jul-24 | Grant | 56,458 | -- | -- | 46% 123.33K to 179.78K | |
| 03-Jul-24 7:55 AM View: | Karabelas Argeris N Director | Regenxbio Inc. (RGNX) | 01-Jul-24 | Option Exercise | 10,000 | $3.76 | $37,600.00 | 89% 11.29K to 21.29K | |
| 03-Jul-24 7:55 AM View: | Karabelas Argeris N Director | Regenxbio Inc. (RGNX) | 01-Jul-24 | Planned Option Sale | 10,000 | $11.27 | $112,691.00 | (47%) 21.29K to 11.29K | |
| 05-Aug-24 6:38 PM View: | Danos Olivier Chief Scientific Officer | Regenxbio Inc. (RGNX) | 28-Jun-24 | Grant | 1,363 | $9.94 | $13,555.00 | 1% 124.85K to 126.22K | |
| 04-Jun-24 4:39 PM View: | Stump David C Director | Regenxbio Inc. (RGNX) | 31-May-24 | Grant | 4,790 | -- | -- | 74% 6.5K to 11.29K | |
| 04-Jun-24 4:40 PM View: | Tasse Daniel Director | Regenxbio Inc. (RGNX) | 31-May-24 | Grant | 4,790 | -- | -- | 74% 6.5K to 11.29K | |
| 04-Jun-24 4:41 PM View: | Fox Allan M. Director | Regenxbio Inc. (RGNX) | 31-May-24 | Grant | 4,790 | -- | -- | < 1% 2.89M to 2.89M | |
| 04-Jun-24 4:42 PM View: | Glucksmann Alexandra Director | Regenxbio Inc. (RGNX) | 31-May-24 | Grant | 4,790 | -- | -- | 74% 6.5K to 11.29K | |
| 04-Jun-24 4:41 PM View: | Bennett Jean Director | Regenxbio Inc. (RGNX) | 31-May-24 | Grant | 4,790 | -- | -- | 74% 6.5K to 11.29K | |
| 04-Jun-24 4:43 PM View: | Migausky George V Director | Regenxbio Inc. (RGNX) | 31-May-24 | Grant | 4,790 | -- | -- | 74% 6.5K to 11.29K | |
| 04-Jun-24 4:43 PM View: | Zachary Jennifer Director | Regenxbio Inc. (RGNX) | 31-May-24 | Grant | 4,790 | -- | -- | 50% 9.51K to 14.3K | |
| 04-Jun-24 4:42 PM View: | Karabelas Argeris N Director | Regenxbio Inc. (RGNX) | 31-May-24 | Grant | 4,790 | -- | -- | 74% 6.5K to 11.29K | |
| 16-May-24 5:06 PM View: | Mills Kenneth T. President and CEO Director | Regenxbio Inc. (RGNX) | 14-May-24 | Option Exercise | 15,000 | $3.76 | $56,400.00 | 4% 408.04K to 423.04K | |
| 16-May-24 5:06 PM View: | Mills Kenneth T. President and CEO Director | Regenxbio Inc. (RGNX) | 14-May-24 | Planned Option Sale | 15,000 | $15.81 | $237,222.00 | (4%) 423.04K to 408.04K | |
| 17-Apr-24 5:05 PM View: | Mills Kenneth T. President and CEO Director | Regenxbio Inc. (RGNX) | 15-Apr-24 | Planned Option Sale | 15,000 | $18.19 | $272,871.00 | (4%) 423.04K to 408.04K | |
| 17-Apr-24 5:05 PM View: | Mills Kenneth T. President and CEO Director | Regenxbio Inc. (RGNX) | 15-Apr-24 | Option Exercise | 15,000 | $3.76 | $56,400.00 | 4% 408.04K to 423.04K | |
| 21-Mar-24 5:20 PM View: | Vasista Vittal Chief Financial Officer | Regenxbio Inc. (RGNX) | 19-Mar-24 | Option Exercise | 20,041 | $3.76 | $75,354.20 | 9% 226.49K to 246.53K | |
| 18-Mar-24 5:03 PM View: | Mills Kenneth T. President and CEO Director | Regenxbio Inc. (RGNX) | 14-Mar-24 | Option Exercise | 15,000 | $3.76 | $56,400.00 | 4% 408.04K to 423.04K | |
| 18-Mar-24 5:03 PM View: | Mills Kenneth T. President and CEO Director | Regenxbio Inc. (RGNX) | 14-Mar-24 | Planned Option Sale | 15,000 | $21.86 | $327,942.00 | (4%) 423.04K to 408.04K | |
| 07-Mar-24 6:05 PM View: | Pakola Steve Chief Medical Officer | Regenxbio Inc. (RGNX) | 05-Mar-24 | Planned Option Sale | 12,878 | $28.36 | $365,220.00 | (11%) 120.07K to 107.19K | |
| 07-Mar-24 6:05 PM View: | Pakola Steve Chief Medical Officer | Regenxbio Inc. (RGNX) | 05-Mar-24 | Option Exercise | 12,878 | $22.25 | $286,536.00 | 12% 107.19K to 120.07K | |
| 16-Feb-24 6:28 PM View: | Mills Kenneth T. President and CEO Director | Regenxbio Inc. (RGNX) | 14-Feb-24 | Planned Option Sale | 15,000 | $16.76 | $251,349.00 | (4%) 423.04K to 408.04K | |
| 16-Feb-24 6:28 PM View: | Mills Kenneth T. President and CEO Director | Regenxbio Inc. (RGNX) | 14-Feb-24 | Option Exercise | 15,000 | $3.76 | $56,400.00 | 4% 408.04K to 423.04K | |
| 18-Jan-24 6:39 PM View: | Mills Kenneth T. President and CEO Director | Regenxbio Inc. (RGNX) | 16-Jan-24 | Planned Option Sale | 45,000 | $15.18 | $682,992.00 | (10%) 453.04K to 408.04K | |
| 18-Jan-24 6:39 PM View: | Mills Kenneth T. President and CEO Director | Regenxbio Inc. (RGNX) | 16-Jan-24 | Option Exercise | 45,000 | $3.76 | $169,200.00 | 11% 408.04K to 453.04K | |
| 04-Jan-24 4:23 PM View: | Pakola Steve Chief Medical Officer | Regenxbio Inc. (RGNX) | 03-Jan-24 | Sale (Planned) | 17,237 | $17.39 | $299,789.00 | (14%) 124.43K to 107.19K | |
| 04-Jan-24 4:22 PM View: | Danos Olivier Chief Scientific Officer | Regenxbio Inc. (RGNX) | 02-Jan-24 | Payment of Exercise | 8,410 | $17.95 | $150,960.00 | (6%) 133.26K to 124.85K | |
| 04-Jan-24 4:23 PM View: | Pakola Steve Chief Medical Officer | Regenxbio Inc. (RGNX) | 02-Jan-24 | Payment of Exercise | 10,385 | $17.95 | $186,411.00 | (8%) 134.81K to 124.43K | |
| 04-Jan-24 4:06 PM View: | Christmas Patrick J. Chief Legal Officer | Regenxbio Inc. (RGNX) | 02-Jan-24 | Payment of Exercise | 7,893 | $17.95 | $141,679.00 | (6%) 123.65K to 115.76K |
